Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

HIV/AIDS

RSS  

Articles

  • iPNewbe: What's protecting who and how?

    The public is getting savvier by the day regarding what is expected in healthcare facilities from an infection prevention standpoint. It wasn't too long ago that communication with the general public was an uncommon occurrence.
  • Abstract & Commentary: Flawed data mar reports of BSIs

    Central line-associated infections, particularly bloodstream infections (BSI), remain a huge issue in our technological age. Four academic medical centers were used to accumulate 165,963 central-line days associated with 241,518 patient days.
  • Flu recs redefine HCW protection

    In a lingering legacy of the H1N1 pandemic, stronger protections are now advised for seasonal influenza than was the case prior to the emergence of the novel H1N1 strain. That distinctive status was recently highlighted in new influenza guidance in California.
  • Fatal infection of NDM-1 included gene transfer

    Threatening to spread to North America after originating in hospitals in India, the pan-resistant New Delhi metallo-beta-lactamase (NDM-1) enzyme has been linked to a fatal infection in Canada.
  • Infection preventionists must hold the line as pan-resistant gram negatives spread

    The continuing global emergence of multidrug resistant gram negative pathogens bugs that are virtually impervious to all antibiotics and can transfer resistance mechanisms between species means infection prevention is more critical than ever during every patient encounter.
  • Drug stewardship: A failure to de-escalate

    Robert Rapp, PharmD, professor of pharmacy at the University of Kentucky Chandler Medical Center, is an outspoken advocate for antibiotic stewardship to preserve the efficacy of our remaining antibiotics against rising drug resistance.
  • Detecting, stopping new resistant bugs

    The Centers for Disease Control and Prevention guidelines to prevent infection with carbapenem-resistant pathogens include the following recommendations.
  • CDC issues STD treatment update

    The Centers for Disease Control and Prevention has released new guidelines for the treatment of persons who have or are at risk for sexually transmitted diseases (STDs).
  • FDA Notifications

    On Nov. 10, 2010, the Food and Drug Administration (FDA) approved tessamorelin (Egrifta®) to treat HIV patients with lipodystrophy, a condition in which excess fat develops in different areas of the body, most notably around the liver, stomach, and other abdominal organs (visceral body fat).
  • Don't test, don't know: The danger of denial

    Results of a new analysis of 21 major U.S. cities from the Centers for Disease Control and Prevention indicate approximately one in five (19%) men who have sex with men (MSM) in a study is infected with HIV, and nearly half (44%) of those men are unaware of their infection.